SPAIN | ACTIS
06/11/2019
Límite 04 Ago 2021
Oferta Empresarial
Ref.
BOKR20200706001
A leading biotech Korean company specialized in producing high-quality diagnostic kit for COVID-19 seeks for global partners
The Korean company specializing in multiplex molecular diagnostics with the aim of completing localization of genetic technology is offering a COVID-19 diagnostic kit. The kit is based on real-time PCR method which features high sensitivity and accuracy. Also, this kit detects 3 targets per tube which make more efficient diagnosis available. It takes only 1 hour 30 minuntes for Real-Time PCR and is compatible with 4 types of Real-Time PCR machines.
Socios

logotipo CEOE Aragónlogotipo ITAlogotipo Cámara Toledologotipo FEDAlogotipo UCLM
logotipo FUNDECYT-PCTEX logotipo ADERlogotipo FERlogotipo AINlogotipo UNAV

27/02/2024

Requerimientos: IE 6.0+, FF 1.5+ 1024x768+ | Aviso Legal | Confidencialidad

06/11/2019